122 related articles for article (PubMed ID: 26851089)
21. The use of Au@SiO2 shell-isolated nanoparticle-enhanced Raman spectroscopy for human breast cancer detection.
Zheng C; Liang L; Xu S; Zhang H; Hu C; Bi L; Fan Z; Han B; Xu W
Anal Bioanal Chem; 2014 Sep; 406(22):5425-32. PubMed ID: 24958347
[TBL] [Abstract][Full Text] [Related]
22. Evaluating the utility of trefoil factor 1 as a mammary-specific immunostain compared and in conjunction with GATA-3 and mammaglobin in the distinction between carcinoma of breast and lung.
Wells JM; Ginter PS; Liu Y; Chen Z; Narula N; Shin SJ
Am J Clin Pathol; 2015 Sep; 144(3):444-51. PubMed ID: 26276775
[TBL] [Abstract][Full Text] [Related]
23. Detection of mammaglobin in the sera of patients with breast cancer.
Fanger GR; Houghton RL; Retter MW; Hendrickson RC; Babcook J; Dillon DC; Durham MD; Reynolds LD; Johnson JC; Carter D; Fleming TP; Roche PC; Persing DH; Reed SG
Tumour Biol; 2002; 23(4):212-21. PubMed ID: 12499777
[TBL] [Abstract][Full Text] [Related]
24. GATA3 expression in morphologic subtypes of breast carcinoma: a comparison with gross cystic disease fluid protein 15 and mammaglobin.
Wendroth SM; Mentrikoski MJ; Wick MR
Ann Diagn Pathol; 2015 Feb; 19(1):6-9. PubMed ID: 25544392
[TBL] [Abstract][Full Text] [Related]
25. The role of lipid droplets and adipocytes in cancer. Raman imaging of cell cultures: MCF10A, MCF7, and MDA-MB-231 compared to adipocytes in cancerous human breast tissue.
Abramczyk H; Surmacki J; Kopeć M; Olejnik AK; Lubecka-Pietruszewska K; Fabianowska-Majewska K
Analyst; 2015 Apr; 140(7):2224-35. PubMed ID: 25730442
[TBL] [Abstract][Full Text] [Related]
26. Raman 'optical biopsy' of human breast cancer.
Abramczyk H; Brozek-Pluska B; Surmacki J; Jablonska-Gajewicz J; Kordek R
Prog Biophys Mol Biol; 2012 Jan; 108(1-2):74-81. PubMed ID: 22122914
[TBL] [Abstract][Full Text] [Related]
27. Precursors and preinvasive lesions of the breast: the role of molecular prognostic markers in the diagnostic and therapeutic dilemma.
Zagouri F; Sergentanis TN; Zografos GC
World J Surg Oncol; 2007 May; 5():57. PubMed ID: 17540032
[TBL] [Abstract][Full Text] [Related]
28. Utility of mammaglobin and gross cystic disease fluid protein-15 (GCDFP-15) in confirming a breast origin for recurrent tumors.
Chia SY; Thike AA; Cheok PY; Tan PH
Breast; 2010 Oct; 19(5):355-9. PubMed ID: 20347310
[TBL] [Abstract][Full Text] [Related]
29. A small subgroup of operable breast cancer patients with poor prognosis identified by quantitative real-time RT-PCR detection of mammaglobin A and trefoil factor 1 mRNA expression in bone marrow.
Tjensvoll K; Gilje B; Oltedal S; Shammas VF; Kvaløy JT; Heikkilä R; Nordgård O
Breast Cancer Res Treat; 2009 Jul; 116(2):329-38. PubMed ID: 18846421
[TBL] [Abstract][Full Text] [Related]
30. Raman spectroscopy and imaging: applications in human breast cancer diagnosis.
Brozek-Pluska B; Musial J; Kordek R; Bailo E; Dieing T; Abramczyk H
Analyst; 2012 Aug; 137(16):3773-80. PubMed ID: 22754917
[TBL] [Abstract][Full Text] [Related]
31. Tenascin C is a prognostic determinant and potential cancer-associated fibroblasts marker for breast ductal carcinoma.
Yang Z; Ni W; Cui C; Fang L; Xuan Y
Exp Mol Pathol; 2017 Apr; 102(2):262-267. PubMed ID: 28223108
[TBL] [Abstract][Full Text] [Related]
32. Rapid and sensitive phenotypic marker detection on breast cancer cells using surface-enhanced Raman scattering (SERS) imaging.
Lee S; Chon H; Lee J; Ko J; Chung BH; Lim DW; Choo J
Biosens Bioelectron; 2014 Jan; 51():238-43. PubMed ID: 23973735
[TBL] [Abstract][Full Text] [Related]
33. [Mammaglobin in peripheral blood and tumor in breast cancer patients].
Bozhenko VK; Kharchenko NV; Vaskevich EF; Kudinova EA; Oorzhak AV; Rozhkova NI; Trotsenko ID
Biomed Khim; 2016 May; 62(4):453-7. PubMed ID: 27563000
[TBL] [Abstract][Full Text] [Related]
34. GATA3 expression in clinically useful groups of breast carcinoma: a comparison with GCDFP15 and mammaglobin for identifying paired primary and metastatic tumors.
Yang Y; Lu S; Zeng W; Xie S; Xiao S
Ann Diagn Pathol; 2017 Feb; 26():1-5. PubMed ID: 28038704
[TBL] [Abstract][Full Text] [Related]
35. GATA-binding protein 3, gross cystic disease fluid protein-15 and mammaglobin have distinct prognostic implications in different invasive breast carcinoma subgroups.
Ni YB; Tsang JY; Chan SK; Tse GM
Histopathology; 2015 Jul; 67(1):96-105. PubMed ID: 25425335
[TBL] [Abstract][Full Text] [Related]
36. Ductal carcinoma in situ: MR imaging-histopathologic correlation.
Gilles R; Zafrani B; Guinebretière JM; Meunier M; Lucidarme O; Tardivon AA; Rochard F; Vanel D; Neuenschwander S; Arriagada R
Radiology; 1995 Aug; 196(2):415-9. PubMed ID: 7617854
[TBL] [Abstract][Full Text] [Related]
37. Monitoring glycosylation metabolism in brain and breast cancer by Raman imaging.
Kopec M; Imiela A; Abramczyk H
Sci Rep; 2019 Jan; 9(1):166. PubMed ID: 30655566
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of a panel of tumor markers for molecular detection of circulating cancer cells in women with suspected breast cancer.
Reinholz MM; Nibbe A; Jonart LM; Kitzmann K; Suman VJ; Ingle JN; Houghton R; Zehentner B; Roche PC; Lingle WL
Clin Cancer Res; 2005 May; 11(10):3722-32. PubMed ID: 15897569
[TBL] [Abstract][Full Text] [Related]
39. GATA3: a promising marker for metastatic breast carcinoma in serous effusion specimens.
Shield PW; Papadimos DJ; Walsh MD
Cancer Cytopathol; 2014 Apr; 122(4):307-12. PubMed ID: 24421220
[TBL] [Abstract][Full Text] [Related]
40. Raman imaging and statistical methods for analysis various type of human brain tumors and breast cancers.
Kopec M; Błaszczyk M; Radek M; Abramczyk H
Spectrochim Acta A Mol Biomol Spectrosc; 2021 Dec; 262():120091. PubMed ID: 34175760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
